2d
GlobalData on MSNFDA clears Caristo’s AI-powered CAD diagnostic softwareThe software can determine the extent and severity of coronary plaque build-up implicated in coronary artery disease.
The CaRi-Plaque technology supports non-invasive analysis of coronary anatomy and pathology from routine coronary computed ...
Stamford, Connecticut Wednesday, March 12, 2025, 15:00 Hrs [IST] ...
FDA 510(k) clearance of Caristo's CaRi-Plaque technology advances AI innovator's U.S. commercialization, as it looks to roll out to hospitals, health systems and longevity clinicsThe CaRi-Plaque ...
Briahnna Thooft, learned a congenital heart defect has been missed her entire life. Thooft has undergone two surgeries and ...
Composite of coronary heart disease death and non-fatal myocardial infarction was less frequent in the CCTA group compared to ...
IT’S REALLY A STARTLING TOPIC TO TALK ABOUT, BUT ACCORDING TO THE AMERICAN HEART ASSOCIATION, THE NUMBER ONE CAUSE OF DEATH OF STUDENT ATHLETES IS SUDDEN CARDIAC ARREST. THE SAME CAN BE SAID FOR ...
Coronary artery disease, CAD, is a condition where the arteries that supply blood to the heart muscle become clogged and narrow, making it difficult for blood and oxygen to reach the muscles of ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Methods A multi-centre audit was undertaken covering the three-year period when FFR-CT was centrally funded in England. For coronary computed tomography angiograms (CCTAs) submitted for FFR-CT, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results